Welcome to our dedicated page for AIxCrypto Holdings SEC filings (Ticker: AIXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AIxCrypto Holdings, Inc. filings document the company's transition from Qualigen Therapeutics into an AI and blockchain-enabled digital infrastructure business. Recent Form 8-K reports cover annual results, strategic repositioning, capital formation, consulting arrangements, and material agreements tied to blockchain architecture, funding strategy, RWA tokenization, AI agents, and Embodied AI ecosystems.
The filing record also includes amendments to entrusted investment arrangements involving FFAI securities, auditor change disclosures, and proxy materials for shareholder voting matters. These documents describe governance, financial reporting, capital-structure matters, material-event disclosures, and the company's public-company controls as it develops infrastructure, protocol, and application-layer initiatives.
AIxCrypto Holdings, Inc. shifted fully from legacy biotechnology into a crypto- and AI-focused model, emphasizing Real-World Asset tokenization and an Embodied AI ecosystem while winding down all historical biopharma programs. For the six months ended June 30, 2026, it recorded a net loss of $10,266,621, driven by operating expenses of $7,293,046, a $2,929,946 net loss on digital assets, and a $375,844 loss on settlement of a Marizyme note.
Balance sheet strength deteriorated sharply: cash fell to $577,328 from $19,332,707 at December 31, 2025, while exchange-traded digital assets stood at $5,212,903 at fair value versus a $10,433,028 cost basis. Total assets declined to $7,402,799 and stockholders’ equity to $5,681,796, with 20,234,993 common shares outstanding after large conversions of Series B preferred stock. Operating activities used $7,939,909 of cash in six months, and financing activities used $12,132,000, including a $12,000,000 parent-company equity investment held at cost.
Management discloses that limited cash, absence of committed financing, volatile digital-asset values, and lack of recurring operating revenue collectively raise substantial doubt about the company’s ability to continue as a going concern for one year after issuance of these financial statements. RoboShare, an on-demand robot sharing marketplace publicly launched in June 2026, has not yet generated revenue; the first rental is targeted for August 2026, subject to execution. After quarter-end, the company advanced $500,000 to majority stockholder Faraday Future Intelligent Electric Inc. under a contemplated credit facility and entered a one-year consulting agreement with Aibot US Operation Inc. requiring $50,000 in monthly fees.
AIxCrypto Holdings reported Q2 2026 results that emphasize a pivot from planning to execution around its new RoboShare robot‑sharing marketplace. RoboShare launched in June and will begin a Los Angeles pilot, with expansion to other cities dependent on early usage, economics and partner readiness. The company is also internally testing AI Agent products and anticipates initial revenue from Agentir beginning in the third quarter of 2026.
For the quarter ended June 30, 2026, revenue was zero and total operating expenses were $2,959,325, down 32% from the first quarter as cost‑normalization measures sharply reduced sales and marketing spending. Net loss was $4,187,605, improving from $6,079,016 in Q1 but larger than a year earlier, and included a non‑cash $984,364 loss on digital assets and a one‑time $375,844 loss on settlement of Marizyme notes. Net loss per share was $(0.21) for the quarter. As of June 30, 2026, cash and cash equivalents were $577,328 and digital assets had a fair value of $5,212,903, for a combined carrying value of about $5.8 million; total stockholders’ equity was $5,681,796. Net cash used in operating activities was $7,939,909 for the first half of 2026, and the company reported no debt, while maintaining capital priorities of RoboShare commercialization and expense discipline.
AIxCrypto Holdings, Inc. entered into a Consulting Agreement with Aibot US Operation Inc effective July 16, 2026 through July 15, 2027. Aibot will supply a four-person team covering finance, capital markets, and human resources/legal coordination, generally on-site five business days per week.
Compensation consists of a $50,000 monthly consulting fee, paid in semi-monthly installments, plus reimbursement of reasonable documented expenses capped at $500 per month unless pre-approved. One finance team member works on a hybrid schedule, reflected in a 20% fee discount for that role.
Governance terms allow either party to terminate with at least 15 days’ written notice, or on 24 hours’ notice for material breach, with immediate termination for specified confidentiality or non-solicitation breaches. Aibot is minority owned by CEO and director Jerry Wang, who also sits on its board, so the arrangement is a related party transaction. Disinterested board members and the Audit Committee reviewed and approved the agreement as fair and on terms no less favorable than could be obtained from an unaffiliated third party.
AIxCrypto Holdings, Inc. is registering up to 55,000,000 shares of common stock for resale by Gold King Arthur Holding Limited under a committed equity financing. The company may sell shares to this investor for an aggregate purchase price of up to $50,000,000 via VWAP-based purchases.
AIxCrypto develops infrastructure at the intersection of artificial intelligence and blockchain, focusing on tokenization of real-world assets and Embodied AI systems. It rebranded after a prior therapeutics business, remains a smaller reporting company, and its new platforms are early stage and have not generated material revenue.
Shares are issued at 93% of the lowest daily VWAP over three trading days, with a 3% Draw Fee, and are subject to a 9.99% Beneficial Ownership Limitation and a Nasdaq 19.99% Exchange Cap (4,044,975 shares) until stockholder approval. As of July 24, 2026, 20,234,993 shares were outstanding; if all 55,000,000 VWAP Shares were issued, they would represent about 73.10% of outstanding shares, meaning substantial potential dilution and share-price pressure from resales. Faraday Future Intelligent Electric Inc., the controlling stockholder, can provide the required written consent and may also receive up to $2,000,000 in unsecured credit from AIxCrypto, creating related-party and conflict-of-interest considerations.
AIxCrypto Holdings, Inc. filed an amendment to its annual report for the year ended December 31, 2025 to provide detailed Part III information on directors, executive compensation, security ownership, related-party transactions and auditor fees. The amendment does not change previously reported financial statements.
The company has a five-member board led by Chief Executive Officer Jiawei Wang and President and Chief Financial Officer Jie Sheng, with three Nasdaq-qualified independent directors and standing Audit, Compensation, and Nominating and Corporate Governance committees operating under formal charters. A code of business conduct, insider trading policy, hedging prohibition and claw-back policy are in place, and no disqualifying legal proceedings or family relationships among directors and officers are disclosed.
There were 20,234,993 shares of common stock outstanding as of March 23, 2026, and the market value of non‑affiliate holdings was $5,581,476 at $3.413 per share on June 30, 2025. Faraday Future Intelligent Electric Inc. beneficially owns 13,357,079 shares (66.0%). 2025 net loss attributable to AIxCrypto was $16.9 million. Principal executive officer compensation totaled $524,542 in 2025, with additional salaries of $75,000 for Jiawei Wang and $37,500 for then-CFO Koti Meka. Related-party items include a $10.0 million prepaid investment tied to Faraday shares, historical convertible debt with Alpha Capital Anstalt and Yi Hua Chen that is no longer outstanding, and warrant liabilities of about $72,000.
AIxCrypto Holdings, Inc. furnished an 8-K to share a press release about its debut at Automate 2026, a major automation and robotics exhibition in Chicago. The company officially launched RoboShare, a matchmaking platform for on-demand robot rentals, and introduced AIXC01, an infrastructure network for autonomous assets built around Identity, Attestation, Access, and Settlement.
The press release also outlines a broader Embodied AI + Web3 Robot Ecosystem strategy, including a “Robot Second Life Cycle” concept and a ground-air integration approach for the low-altitude economy. The information is furnished under Regulation FD, not deemed filed, and is subject to customary forward-looking statement disclaimers and safe-harbor protections.
AIxCrypto Holdings, Inc. entered into a common share purchase agreement with Gold King Arthur Holding Limited, creating a flexible equity financing facility. The company may sell up to $50,000,000 of common shares, or up to 19.99% of the voting power outstanding before signing, whichever is less, unless shareholders later approve a higher level.
Shares can be drawn over time via VWAP Purchase Notices, with the purchase price set at 93% of the lowest volume-weighted average price over a three-day window, and a 3.0% draw fee retained by the purchaser. AIxCrypto paid a $100,000 upfront fee at signing.
The company plans to register resales of these shares on Form S-1 within set deadlines and must seek shareholder approval to issue shares above the exchange cap. The agreement runs until the earlier of its 24‑month term, full use of the $50 million commitment, delisting, or specified insolvency or breach events.
AIxCrypto Holdings, Inc. director Shi Chen has filed an initial Form 3, which is a required statement of beneficial ownership for company insiders. The filing lists no equity transactions, meaning there are no reported recent purchases, sales, or derivative exercises for Shi Chen in this submission.
AIxCrypto Holdings reported major leadership changes and a strategic exit from its legacy biotechnology business. Co-Chief Executive Officer and director Kevin Richardson II, Chief Financial Officer and director Koti Meka, and President Campbell Becher resigned their roles, with Mr. Meka remaining CFO until June 20, 2026.
The Board appointed director Jie (Jay) Sheng as President immediately and as Chief Financial Officer effective June 21, 2026. His offer includes a $400,000 base salary, up to $200,000 annual bonus, and proposed equity awards subject to Board approval and share availability. Jerry Wang and Chen Shi were also appointed as directors, with Mr. Shi deemed an independent director and expected to chair the Audit Committee.
The Board approved a structured wind-down of the company’s legacy biotechnology segment after reviewing strategic alternatives. The company is evaluating potential charges, asset impairments, and other costs from this discontinuation and plans to provide further details in its next periodic SEC report.
AIxCrypto Holdings, Inc. entered into a material agreement to sell its loan and related rights tied to Marizyme, Inc. to CABG ACQUISITION CORP. The Note Package includes an amended secured promissory note with outstanding principal of about $4,771,142 at 18% interest, a $1,750,000 co-development note, and a security interest in substantially all Marizyme assets.
In return, AIxCrypto will receive $100,000 in cash, royalty payments equal to 10% of Net Revenue on cumulative Net Revenue above $20,000,000, and a 4.99% membership interest in the Buyer. AIxCrypto also gains customary preemptive and registration rights. The closing will occur on a mutually agreed date, with either party able to terminate if it has not closed within 90 days.